Loading...
SP Accure Labs Private Limited — Lenalidomide Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #9 for Lenalidomide · $149.5K export value · DGFT Verified
SP Accure Labs Private Limited is the #9 Indian exporter of Lenalidomide with $149.5K in export value and 7 verified shipments. SP Accure Labs Private Limited holds a 0.0% market share in Lenalidomide exports across 2 countries. The company exports 14 pharmaceutical products worth $3.5M across 3 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $6.0M | 119 | 29.7% |
| NETHERLANDS | $3.8M | 128 | 19.2% |
| BELGIUM | $2.5M | 88 | 12.7% |
| MOROCCO | $1.1M | 26 | 5.5% |
| MALTA | $1.0M | 137 | 5.2% |
| TURKEY | $836.3K | 102 | 4.2% |
| CANADA | $800.0K | 16 | 4.0% |
| VIETNAM | $703.5K | 17 | 3.5% |
| FRANCE | $674.2K | 14 | 3.4% |
| LEBANON | $568.6K | 43 | 2.8% |
India exports Lenalidomide to 122 countries. The top destination is UNITED STATES (29.7%), followed by NETHERLANDS and BELGIUM.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| YUSEN LOGISTICS BENELUX BELGIUM | BELGIUM | $2.5M | 79 |
| BROCACEF NL HUB | NETHERLANDS | $2.0M | 47 |
| AUROBINDO PHARMA USA., INC, | UNITED STATES | $1.9M | 38 |
| AUROBINDO PHARMA USA INC | UNITED STATES | $650.0K | 13 |
| SUN PHARMACEUTICAL INDUSTRIESINC. | UNITED STATES | $400.0K |
India exported $30.4M worth of Lenalidomide through 2,724 shipments from 237 suppliers to 122 countries, serving 557 buyers globally. SP Accure Labs Private Limited contributes $149.5K to this total, accounting for 0.0% of India's Lenalidomide exports.
SP Accure Labs Private Limited's average Lenalidomide shipment value is $21.4K per consignment, based on 7 shipments totaling $149.5K.
SP Accure Labs Private Limited ranks #9 among 237 Indian Lenalidomide exporters with a 0.0% market share. The top 3 exporters are EUGIA PHARMA SPECIALITIES LIMITED ($9.4M), RELIANCE LIFE SCIENCES PRIVATE LIMITED ($8.3M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($7.2M). SP Accure Labs Private Limited processed 7 shipments to 2 destination countries.
What SP Accure Labs Private Limited must comply with to export Lenalidomide to its top destination countries
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | DR REDDYS LABORATORIES LIMITED | $200.0K | 4 | 3 | $50.0K |
| 8 | DR REDDY S LABORATORIES LIMITED | $150.0K | 3 | 2 | $50.0K |
| 9 | SP ACCURE LABS PRIVATE LIMITED ★ | $149.5K | 7 | 2 | $21.4K |
| 10 | RMPL PHARMA LLP | $145.7K | 82 | 10 | $1.8K |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 740 | 27.2% |
| SAHAR AIR | 688 | 25.3% |
| DELHI AIR CARGO ACC (INDEL4) | 187 | 6.9% |
| Bombay Air | 180 | 6.6% |
| DELHI AIR | 140 | 5.1% |
| Bombay Air Cargo | 88 | 3.2% |
| HYDERABAD ACC (INHYD4) | 78 | 2.9% |
| HYDERABAD AIR | 68 | 2.5% |
SP Accure Labs Private Limited also exports these advanced oncology products. Each links to the detailed product page.
SP Accure Labs Private Limited exports 14 products worth $3.5M. Beyond Lenalidomide, top products include Paclitaxel, Protein, Bortezomib, Pazopanib, Cyclophosphamide. View the complete SP Accure Labs Private Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Lenalidomide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for SP Accure Labs Private Limited's Lenalidomide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SP Accure Labs Private Limited
Full Company Profile →
14 products · $3.5M total trade · 3 categories
| 8 |
| SUN PHARMACEUTICAL INDUSTRIES,INC. | UNITED STATES | $350.0K | 7 |
| SUN PHARMACEUTICAL INDUSTRIES INC | UNITED STATES | $350.0K | 7 |
| CIPLA USA INC UPS SUPPLY CHAIN SOL | UNITED STATES | $200.0K | 4 |
| SUN PHARMACEUTICAL INDUSTRIES,INC.. | UNITED STATES | $100.0K | 2 |
| XXC (XXNG XXNG)XXO XXD | JAPAN | $100.0K | 2 |
India's Lenalidomide is purchased by 557 buyers worldwide. The top buyer is YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), followed by BROCACEF NL HUB and AUROBINDO PHARMA USA., INC,.
| 11 |
| MYLAN LABORATORIES LIMITED |
| $133.2K |
| 20 |
| 6 |
| $6.7K |
SP Accure Labs Private Limited ranks #9 among 237 Indian Lenalidomide exporters. Average shipment value of $21.4K compared to the market average of $128.1K. The closest competitors by value are DR REDDYS LABORATORIES LIMITED and DR REDDY S LABORATORIES LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 122+ countries, 557+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for SP Accure Labs Private Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Lenalidomide. For current shipment-level data, contact TransData Nexus.